Photodynamic immunotherapy using ADU-S100-modified nanoparticles to treat triple-negative breast cancer-Reference-Cited by-同舟云学术

Photodynamic immunotherapy using ADU-S100-modified nanoparticles to treat triple-negative breast cancer

Published:2023-04 Issue:9 Volume:18 Page:755-767
ISSN:1743-5889
Container-title:Nanomedicine
language:en
Short-container-title:Nanomedicine

Author:

Ge Tong¹^ORCID,Ge Wenshu²,Zhang Ludan²^ORCID,Yu Guohui¹^ORCID,Li Yi¹^ORCID,Sun Lisha²,Dong Fan²,Yao Zhi¹,Shi Lei¹,Wang Yuguang²

Affiliation:

1. Department of Immunology, Key Laboratory of Immune Microenvironment & Disease of the Educational Ministry of China, Tianjin Key Laboratory of Cellular & Molecular Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China

2. Center of Digital Dentistry/Department of Prosthodontics, National Center of Stomatology, National Clinical Research Center for Oral Diseases, National Engineering Laboratory for Digital & Material Technology of Stomatology, Beijing Key Laboratory of Digital Stomatology, NHC Research Center of Engineering & Technology for Computerized Dentistry, Department of General Dentistry II, Central Laboratory, Peking University School & Hospital of Stomatology, Beijing, 100081, China

Abstract

Aim: STING agonists in immunotherapy show great promise and are currently in clinical trials. Combinations of STING agonists with other therapies remain underexplored. This study aimed to combine STING agonist-mediated immunotherapy with photodynamic therapy to treat breast cancer. Methods: STING agonist (ADU-S100)-functionalized porphyrin-based nanoparticles (NP-AS) were prepared and their antitumor properties in terms of cell apoptosis/necrosis and immune activation in triple-negative breast cancer were evaluated. Results: NP-AS induced tumor cell apoptosis/necrosis, activated the innate immune response and exhibited useful antitumor effects. Conclusion: NP-AS effectively treated breast cancer.

Funder

National Natural Science Foundation of China

Publisher

Future Medicine Ltd

Subject

Development,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Link

https://www.futuremedicine.com/doi/pdf/10.2217/nnm-2022-0299

Reference43 articles.

1. An overview of triple-negative breast cancer

2. Tumor cell lysate-loaded immunostimulatory spherical nucleic acids as therapeutics for triple-negative breast cancer

3. Cancer statistics, 2015

4. Clinical Applications for Targeted Therapy in Bladder Cancer

5. Amplifying STING activation by cyclic dinucleotide–manganese particles for local and systemic cancer metalloimmunotherapy

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoparticle targeting cGAS-STING signaling in disease therapy;Nano Research;2024-06-15

2. Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies;Cancer Biology & Medicine;2024-01-03